Mind the Gap: eGFR Discordancy and Melphalan Toxicity in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Related Experiment Video

Updated: May 2, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

951

Abinet M Aklilu1, Anushree C Shirali

  • 1Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut.

Kidney360
|April 30, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
cancerkidney dysfunction

More Related Videos

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.0K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.2K

Related Experiment Videos

Last Updated: May 2, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

951
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.0K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.2K

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K

Articles linked to this work by shared authors, journal, and citation graph.

Development of Urinalysis Screening Criteria for Rhabdomyolysis in Acute Kidney Injury.

Kidney360·2026

Glucarpidase for treatment of high-dose methotrexate toxicity.

Blood·2025

The Future of Kidney Care in Low- and Middle-Income Countries: Challenges, Triumphs, and Opportunities.

Kidney360·2024

The VUS Challenge in Cystic Kidney Disease: A Case-Based Review.

Kidney360·2023

Chemotherapy-Associated Thrombotic Microangiopathy.

Kidney360·2023

Dietary Behaviors and Urinary Biomarkers in a Self-Management Support Program Among Low-Income Adults with CKD.

Kidney360·2026

Plasma Proteomics of Cancer Risk Among Patients with CKD.

Kidney360·2026

Cellular Senescence as a Core Mechanistic Link between CKD, Cardiac Fibrosis, and Aging.

Kidney360·2026

Patiromer Efficacy across Kidney Function and Hyperkalemia Subgroups in Heart Failure and Reduced Ejection Fraction: A DIAMOND Post Hoc Analysis.

Kidney360·2026

Patient Perspectives on Their Home Peritoneal Dialysis Experience: A Qualitative Study.

Kidney360·2026

Preeclampsia and Hypertension Disorders of Pregnancy in Women with Kidney Disease.

Kidney360·2026

Cardiac adverse event signals of Bruton's tyrosine kinase inhibitors as primary suspect and in co-reported regimens: a large-scale FAERS pharmacovigilance study.

Frontiers in pharmacology·2026

Can we better evaluate responses in higher-risk myelodysplastic syndromes?

Haematologica·2026

Dynamics and clinical significance of coagulation abnormalities following CAR T-cell therapy.

Haematologica·2026

NEDD4 Promotes Hepatocellular Carcinoma Progression Through Ubiquitin-Dependent Degradation of EPHB6.

Cancer science·2026

Patients' preferences for accepting risks and uncertainty in AML treatments within European public health care systems: a cross-sectional study in Finland, Italy, and Germany.

Leukemia & lymphoma·2026

WNT5A-Associated Osteogenic Enhancement Contributes to the Protective Effects of OPG-Fc in Glucocorticoid-Associated Femoral Head Osteonecrosis.

Biomolecules & therapeutics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us